tbuckley/cabot-search huggingface dataset:
TCT-131 Temporal Vascular Response To Novel, Long, Thin Strut Bioreresorbable Scaffold In The Porcine Coronary Restenosis Model
Authors: Piotr Buszman, Mateusz Kachel, Carlos Fernandez, Maciej Pruski, Aleksandra Blachut, Adam Janas, Magdalena Michalak, Paweł Buszman, Krzysztof Milewski
Journal: Journal of the American College of Cardiology (2017)
Safety and efficacy of alternating treatment with EP2006, a filgrastim biosimilar, and reference filgrastim: a phase III, randomised, double-blind clinical study in the prevention of severe neutropenia in patients with breast cancer receiving myelosuppressive chemotherapy
Authors: K. Blackwell, P. Gascon, A. Krendyukov, S. Gattu, Y. Li, N. Harbeck
Journal: Annals of Oncology (2017)
Natural history and clinical outcome of junctional epidermolysis bullosa generalized intermediate due to a <i>LAMA3</i> mutation
Authors: A. Reimer, A. Schwieger-Briel, Y. He, J. Leppert, F. Schauer, D. Kiritsi, H. Schneider, H. Ott, L. Bruckner-Tuderman, C. Has
Journal: British Journal of Dermatology (2017)

Junctional epidermolysis bullosa (JEB) comprises rare autosomal recessive disorders with a broad spectrum of clinical features and severity. The genetic basis involves mutations in genes encoding proteins of the dermal-epidermal junction, primarily laminin 332. This heterotrimeric glycoprotein consists of laminin α3, β3 and γ2 chains, and the majority of mutations in the respective genes (LAMA3, LAMB3, and LAMC2) lead to premature termination codons resulting in severe generalized JEB (previously Herlitz)1.

This article is protected by copyright. All rights reserved.
NHS boss reveals loss of further 162 000 pieces of medical correspondence
Authors: Gareth Iacobucci
Journal: BMJ (2017)

The loss of more than 700 000 items of NHS clinical correspondence, reported earlier this year,1 has been compounded after officials admitted that a further 162 000 patient files went missing over five years.

The scandal first emerged in March 2016, when it was discovered that hundreds of thousands of files, including test results and diagnoses, were misplaced between 2011 and 2016 before they were delivered to hospitals and GPs in England by NHS Shared Business Services, an agency co-owned by the Department of Health and the IT company Sopra Steria. In June this year a National Audit Office inquiry identified around 1700 cases where patients could have been harmed as a result of the …
VIM-1 carbapenemase-producing Escherichia coli isolated from retail seafood, Germany 2016
Authors: Nicole Roschanski, Sebastian Guenther, Thi Thu Tra Vu, Jennie Fischer, Torsten Semmler, Stephan Huehn, Thomas Alter, Uwe Roesler
Journal: Eurosurveillance (2017)

Carbapenems belong to the group of last resort antibiotics in human medicine. Therefore, the emergence of growing numbers of carbapenemase-producing bacteria in food-producing animals or the environment is worrying and an important concern for the public health sector. In the present study, a set of 45 Enterobacteriaceae isolated from German retail seafood (clams and shrimps), sampled in 2016, were investigated by real-time PCR for the presence of carbapenemase-producing bacteria. One Escherichia coli (ST10), isolated from a Venus clam (Ruditapes philippinarum) harvested in the Mediterranean Sea (Italy), contained the carbapenemase gene blaVIM-1 as part of the variable region of a class I integron. Whole-genome sequencing indicated that the integron was embedded in a Tn3-like transposon that also contained the fluoroquinolone resistance gene qnrS1. Additional resistance genes such as the extended-spectrum beta-lactamase blaSHV-12 and the AmpC gene blaACC-1 were also present in this isolate. Except blaACC-1, all resistance genes were located on an IncY plasmid. These results confirm previous observations that carbapenemase-producing bacteria have reached the food chain and are of increasing concern for public health.
TCT-648 Percutaneous coronary intervention modulates the natural humoral immune response in relation to the degree of coronary artery disease
Authors: Adriano Barbosa, Viviane Sant'Anna, Rodrigo Souza, Guilherme Cintra, Marco Tulio Souza, José Marconi Sousa, Claudia Alves, Antonio Carvalho, Francisco Fonseca, Maria Izar, Magnus Gidlund, Henrique Fonseca
Journal: Journal of the American College of Cardiology (2017)
Delayed versus Immediate Cord Clamping in Preterm Infants
Authors: William Tarnow-Mordi, Jonathan Morris, Adrienne Kirby, Kristy Robledo, Lisa Askie, Rebecca Brown, Nicholas Evans, Sarah Finlayson, Michael Fogarty, Val Gebski, Alpana Ghadge, Wendy Hague, David Isaacs, Michelle Jeffery, Anthony Keech, Martin Kluckow, Himanshu Popat, Lucille Sebastian, Kjersti Aagaard, Michael Belfort, Mohan Pammi, Mohamed Abdel-Latif, Graham Reynolds, Shabina Ariff, Lumaan Sheikh, Yan Chen, Paul Colditz, Helen Liley, Margo Pritchard, Daniele de Luca, Koert de Waal, Peta Forder, Lelia Duley, Walid El-Naggar, Andrew Gill, John Newnham, Karen Simmer, Katie Groom, Philip Weston, Joanna Gullam, Harshad Patel, Guan Koh, Kei Lui, Neil Marlow, Scott Morris, Arvind Sehgal, Euan Wallace, Roger Soll, Leslie Young, David Sweet, Susan Walker, Andrew Watkins, Ian Wright, David Osborn, John Simes
Journal: New England Journal of Medicine (2017)

The preferred timing of umbilical-cord clamping in preterm infants is unclear.We randomly assigned fetuses from women who were expected to deliver before 30 weeks of gestation to either immediate clamping of the umbilical cord (≤10 seconds after delivery) or delayed clamping (≥60 seconds after delivery). The primary composite outcome was death or major morbidity (defined as severe brain injury on postnatal ultrasonography, severe retinopathy of prematurity, necrotizing enterocolitis, or late-onset sepsis) by 36 weeks of postmenstrual age. Analyses were performed on an intention-to-treat basis, accounting for multiple births.Of 1634 fetuses that underwent randomization, 1566 were born alive before 30 weeks of gestation; of these, 782 were assigned to immediate cord clamping and 784 to delayed cord clamping. The median time between delivery and cord clamping was 5 seconds and 60 seconds in the respective groups. Complete data on the primary outcome were available for 1497 infants (95.6%). There was no significant difference in the incidence of the primary outcome between infants assigned to delayed clamping (37.0%) and those assigned to immediate clamping (37.2%) (relative risk, 1.00; 95% confidence interval, 0.88 to 1.13; P=0.96). The mortality was 6.4% in the delayed-clamping group and 9.0% in the immediate-clamping group (P=0.03 in unadjusted analyses; P=0.39 after post hoc adjustment for multiple secondary outcomes). There were no significant differences between the two groups in the incidences of chronic lung disease or other major morbidities.Among preterm infants, delayed cord clamping did not result in a lower incidence of the combined outcome of death or major morbidity at 36 weeks of gestation than immediate cord clamping. (Funded by the Australian National Health and Medical Research Council [NHMRC] and the NHMRC Clinical Trials Centre; APTS Australian and New Zealand Clinical Trials Registry number, ACTRN12610000633088 .).
Novel <i>SEC61G</i>–<i>EGFR</i> Fusion Gene in Pediatric Ependymomas Discovered by Clonal Expansion of Stem Cells in Absence of Exogenous Mitogens
Authors: Tiziana Servidei, Daniela Meco, Valentina Muto, Alessandro Bruselles, Andrea Ciolfi, Nadia Trivieri, Matteo Lucchini, Roberta Morosetti, Massimiliano Mirabella, Maurizio Martini, Massimo Caldarelli, Anna Lasorella, Marco Tartaglia, Riccardo Riccardi
Journal: Cancer Research (2017)

The basis for molecular and cellular heterogeneity in ependymomas of the central nervous system is not understood. This study suggests a basis for this phenomenon in the selection for mitogen-independent (MI) stem-like cells with impaired proliferation but increased intracranial tumorigenicity. MI ependymoma cell lines created by selection for EGF/FGF2-independent proliferation exhibited constitutive activation of EGFR, AKT, and STAT3 and sensitization to the antiproliferative effects of EGFR tyrosine kinase inhibitors (TKI). One highly tumorigenic MI line harbored membrane-bound, constitutively active, truncated EGFR. Two EGFR mutants (ΔN566 and ΔN599) were identified as products of intrachromosomal rearrangements fusing the 3' coding portion of the EGFR gene to the 5'-UTR of the SEC61G, yielding products lacking the entire extracellular ligand-binding domain of the receptor while retaining the transmembrane and tyrosine kinase domains. EGFR TKI efficiently targeted ΔN566/ΔN599-mutant-mediated signaling and prolonged the survival of mice bearing intracranial xenografts of MI cells harboring these mutations. RT-PCR sequencing of 16 childhood ependymoma samples identified SEC61G-EGFR chimeric mRNAs in one infratentorial ependymoma WHO III, arguing that this fusion occurs in a small proportion of these tumors. Our findings demonstrate how in vitro culture selections applied to genetically heterogeneous tumors can help identify focal mutations that are potentially pharmaceutically actionable in rare cancers. Cancer Res; 77(21); 5860-72. ©2017 AACR.
Survival analysis of induction cisplatin (CDDP)-docetaxel (DOC)-bevacizumab (BEV) chemotherapy followed by maintenance BEV-pemetrexed (PEM) therapy in advanced nonsquamous non-small cell lung cancer (NonSq NSCLC): A phase II trial from Okayama Lung Cancer Study Group 0903.
Authors: Naoyuki Nogami, Katsuyuki Hotta, Toshiyuki Kozuki, Hiroshige Yoshioka, Akihiro Nishiyama, Yasushi Fukuda, Masahiro Tabata, Tetsu Shinkai, Mitsune Tanimoto, Katsuyuki Kiura
Journal: Journal of Clinical Oncology (2013)

e19040 Background: BEV maintenance therapy and PEM maintenance therapy in platinum-based chemotherapy yield a significant survival advantage in CALGB and PARAMUNT trials, respectively, but each agent gave only modest impact on survival. We conducted a phase II trial of CDDP-DOC-BEV therapy followed by maintenance BEV-PEM therapy inchemo-naïve advanced NonSq NSCLC. Methods: Forty-one patients (pts) participated in the induction phase, specified as four cycles of induction CDDP (80 mg/m 2 ), DOC (60 mg/m 2 ) and BEV (15 mg/kg) on day 1 of a 21-day cycle. Pts who had not progressed during CDDP-DOC-BEV received maintenance BEV (15 mg/kg) and PEM (500 mg/m 2 ) on day 1 of a 21-day cycle until disease progression. The primary endpoint was PFS, and the secondary endpoints included OS, toxicity, and response. Survival time was calculated from the date of registration. Results: Pt characteristics were as follows: median age: 62 yrs; 76% male; 32% PS 0; 73% stage IV; 93% Ad; 5% EGFR-mutant and 2% ALK-mutant. At the time of this analysis, 34 pts (83%) discontinued the treatment, mainly due to progressive disease (53%). The principal toxicity was myelosuppression (gr. 4 hematological: 21 pts [51%]), and grs. 3/4 febrile neutropenia was observed in 10 (24%) despite no treatment-related deaths. The objective response rate and disease control rate (DCR, % pts with CR/PR/SD) was 82.9% and 97.6%, respectively. Median follow-up time was 15.6 months, and 1-yr PFS rate was 34.2% with 95% confidence interval (CI) of 20.3-48.5%, which met the primary endpoint. Also, 1-yr OS rate was 75.6% (95%CI: 59.4-86.1%). Exploratory analysis for pts with both EGFR- and ALK-wild-typed NonSq NSCLC (n = 16) demonstrated 1-yr PFS and OS rates of 50.0% (24.5-71.1%) and 87.5% (58.6-96.7%), respectively. Also, pts with maintenance therapy (n = 34) had 1-yr PFS and OS rates of 41.2% (24.8-56.9%) and 82.4% (64.9-91.7%), respectively. Conclusions: CDDP-DOC-BEV followed by BEV-PEM maintenance seems highly effective despite moderately toxic profiles in chemo-naïve pts with advanced NonSq NSCLC. Clinical trial information: UMIN000004127.
Structured clinical assessment: a brake to stop the ankle joint ‘rolling’
Authors: Eamonn Delahunt, Phillip A Gribble
Journal: British Journal of Sports Medicine (2018)

Lateral ankle sprains are the most prevalent lower limb musculoskeletal injury incurred by individuals who participate in sports and recreational physical activities.1 2 The prevalence of lateral ankle sprains is also high among the general population and hence, the ‘ simple ankle sprain ’ constitutes a substantial healthcare burden.1 2 

The misconception that acute lateral ankle sprains are benign injuries pervades clinical practice across many healthcare disciplines. Colloquial terms such as a ‘rolled’ ankle or ‘twisted’ ankle are commonly used to describe an acute lateral ankle sprain injury. Up to 50% of individuals who incur an acute lateral ankle sprain do not seek formal healthcare management for their injury.3 

In reality, there is no such thing as a ‘ simple ankle sprain ’.4 This is evidenced by the high propensity for the development of long-term injury-associated symptoms such as persistent …
Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis
Authors: Helen Kelly, Helen A Weiss, Yolanda Benavente, Silvia de Sanjose, Philippe Mayaud, You-lin Qiao, Rui-Mei Feng, Hugo DeVuyst, Vanessa Tenet, Antoine Jaquet, Deborah Konopnicki, Tanvier Omar, Lynette Menezes, Corinna Moucheraud, Risa Hoffman
Journal: The Lancet HIV (2017)

BackgroundThe interactions between antiretroviral therapy (ART) and high-risk human papillomavirus (HPV) and cervical lesions in women living with HIV are poorly understood. We reviewed the association of ART with these outcomes.MethodsWe did a systematic review and meta-analysis by searching MEDLINE and Embase databases for cross-sectional or cohort studies published in English between Jan 1, 1996, and May 6, 2017, which reported the association of ART with prevalence of high-risk HPV or prevalence, incidence, progression, or regression of histological or cytological cervical abnormalities, or incidence of invasive cervcal cancer. Studies were eligible if they reported the association of combination ART or highly active ART use with the following outcomes: high-risk HPV prevalence; squamous intraepithelial lesion (SIL) or cervical intraepithelial neoplasia (CIN) prevalence, incidence, progression, or regression; and invasive cervical cancer incidence among women living with HIV. We did random-effects meta-analyses to estimate summary statistics. We examined heterogeneity with the I2 statistic. This review is registered on the PROSPERO database at the Centre of Reviews and Dissemination, University of York, York, UK (registration number CRD42016039546).FindingsWe identified 31 studies of the association of ART with prevalence of high-risk HPV (6537 women living with HIV) and high grade cervical lesions (HSIL-CIN2+; 9288 women living with HIV). Women living with HIV on ART had lower prevalence of high-risk HPV than did those not on ART (adjusted odds ratio [aOR] 0·83, 95% CI 0·70–0·99; I2=51%, adjusted for CD4 cell count and ART duration), and there was some evidence of association with HSIL-CIN2+ (0·65, 0·40–1·06; I2=30%). 17 studies reported the association of ART with longitudinal cervical lesion outcomes. ART was associated with a decreased risk of HSIL-CIN2+ incidence among 1830 women living with HIV (0·59, 0·40–0·87; I2=0%), SIL progression among 6212 women living with HIV (adjusted hazard ratio [aHR] 0·64, 95% CI 0·54–0·75; I2=18%), and increased likelihood of SIL or CIN regression among 5261 women living with HIV (1·54, 1·30–1·82; I2=0%). In three studies among 15 846 women living with HIV, ART was associated with a reduction in invasive cervical cancer incidence (crude HR 0·40, 95% CI 0·18–0·87, I2=33%).InterpretationEarly ART initiation and sustained adherence is likely to reduce incidence and progression of SIL and CIN and ultimately incidence of invasive cervical cancer. Future cohort studies should aim to confirm this possible effect.FundingUK Medical Research Council.
Second Raffles Dialogue on Human Well-Being and Security
Authors: Tikki Pang, Helena Legido-Quigley, Joanne Su-Yin Yoong, Yap Seng Chong, Khay Guan Yeoh, Dow Rhoon Koh, Kishore Mahbubani, John Eu-Li Wong
Journal: The Lancet (2017)
TCT-465 A US Multicenter Registry For Percutaneous Transcatheter Mitral Valve Replacement Using Balloon Expandable Valve In Patients Who Are At Prohibitive Risk For Surgery
Authors: Divya Ratan Verma, Ashish Pershad, Michael Morse, Michael Morris, George Gellert, Alexis Okoh, Marc Cohen, Kapildeo Lotun, Abhijeet Dhoble, Richard Smalling, Mark Russo, Saibal Kar, Yoshifumi Nakajima, Colin Barker, Soundos Moualla, Brian Whisenant, Chunguang Chen, Tammy Querrey, Steven Yakubov, Daniel Watson, Michael Caskey, Michael J. Reardon, Hao Fang, Timothy Byrne
Journal: Journal of the American College of Cardiology (2017)
TCT-450 Procedural Outcomes of Balloon Valvuloplasty in patients with Bicuspid Aortic valve stenosis: Insights from a National Database
Authors: Arka Chatterjee, Nirmanmoh Bhatia, Manyoo Agarwal, Massoud Leesar, Mark Sasse, Thomas Watts, Sahil Agrawal, Divyanshu Mohananey, Mark Law
Journal: Journal of the American College of Cardiology (2017)
Guideline: An expert panel strongly recommends against arthroscopic knee surgery for degenerative knee disease
Authors: Chris Del Mar
Journal: Annals of Internal Medicine (2017)

ACP Journal Club17 October 2017Guideline: An expert panel strongly recommends against arthroscopic knee surgery for degenerative knee diseaseChris Del Mar, MDChris Del Mar, MDBond University, Gold Coast, Queensland, Australia (C.D.M.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/ACPJC-2017-167-8-038 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Source CitationSiemieniuk RA, Harris IA, Agoritsas T, et al. Arthroscopic surgery for degenerative knee arthritis and meniscal tears: a clinical practice guideline. BMJ. 2017;357:j1982. https://pubmed.ncbi.nlm.nih.gov/28490431Clinical Impact RatingsGIM/FP/GP: Phys Med & Rehab: Rheumatology: References1 Siemieniuk RA, Agoritsas T, Macdonald H, et al. Introduction to BMJ Rapid Recommendations (Editorial). BMJ. 2016;354:i5191. [PMID: 27680768] Google Scholar2 Hoffmann TC, Del Mar C. Patients' expectations of the benefits and harms of treatments, screening, and tests: a systematic review. JAMA Intern Med. 2015;175:274-86. [PMID: 25531451] Google Scholar3 Elwyn G, O’Connor A, Stacey D, et al; International Patient Decision Aids Standards (IPDAS) Collaboration. Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. BMJ. 2006;333:417. [PMID: 16908462] Google Scholar Author, Article, and Disclosure InformationAffiliations: Bond University, Gold Coast, Queensland, Australia (C.D.M.)This article was published at Annals.org on 3 October 2017. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byBeyond Cartilage Repair: The Role of the Osteochondral Unit in Joint Health and Disease 17 October 2017Volume 167, Issue 8Page: JC38KeywordsArthroscopyGrading of Recommendations Assessment Development and EvaluationKneesObservational studiesOrthopedicsOsteoarthritisRheumatologySurgeonsSystematic reviewsTreatment guidelines ePublished: 17 October 2017 Issue Published: 17 October 2017 Copyright & PermissionsCopyright © 2017 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
Pleural effusion as a late complication of intravesical BCG treatment
Authors: Ailish Nimmo, Amy Gray, Aarti Patel, Joseph MacKenzie, Ian Fairbairn
Journal: Thorax (2017)

Amy Gray (Junior Doctor) : An 88-year-old man with a background of transitional cell bladder cancer diagnosed in 2012 was referred to the ambulatory care clinic with a 1-month history of increasing breathlessness. He had constitutional symptoms of fatigue, reduced appetite and weight loss for the past 4 months. There was no history of cough, fever or night sweats. His bladder cancer had been resected in 2013 with pathology confirming this as a G3 pT1 transitional cell cancer (TCC), and there was no evidence of recurrence on surveillance flexible cystoscopies. He had been on maintenance intravesical BCG therapy since this time, last given 8 months previously. Of note, his last BCG instillation had been traumatic with haematuria postprocedure. He was an ex-smoker of 25 years and had worked within manufacturing and sales in the wallpaper industry. He had no known exposure to asbestos or TB and no animal exposure.

He had a chest X-ray, which showed a left-sided pleural effusion taking up 50% of the hemithorax (figure 1). A CT chest was then performed, which confirmed a moderate left-sided pleural effusion and also showed a spiculated 16 mm nodule in the left upper lobe and a spiculated 23 mm nodule in the right upper lobe. These were not present on a previous CT in 2014.



Figure 1 
Initial chest X-ray showing large left-sided pleural effusion.



Ian Fairbairn (Respiratory Consultant) : In summary, this elderly man with a background of bladder TCC presents with a large left-sided pleural effusion and pulmonary nodules. A unilateral effusion in the presence of pulmonary nodules is more likely to be exudative than transudative in nature, …
Advillin acts upstream of phospholipase C ϵ1 in steroid-resistant nephrotic syndrome
Authors: Jia Rao, Shazia Ashraf, Weizhen Tan, Amelie T. van der Ven, Heon Yung Gee, Daniela A. Braun, Krisztina Fehér, Sudeep P. George, Amin Esmaeilniakooshkghazi, Won-Il Choi, Tilman Jobst-Schwan, Ronen Schneider, Johanna Magdalena Schmidt, Eugen Widmeier, Jillian K. Warejko, Tobias Hermle, David Schapiro, Svjetlana Lovric, Shirlee Shril, Ankana Daga, Ahmet Nayir, Mohan Shenoy, Yincent Tse, Martin Bald, Udo Helmchen, Sevgi Mir, Afig Berdeli, Jameela A. Kari, Sherif El Desoky, Neveen A. Soliman, Arvind Bagga, Shrikant Mane, Mohamad A. Jairajpuri, Richard P. Lifton, Seema Khurana, Jose C. Martins, Friedhelm Hildebrandt
Journal: Journal of Clinical Investigation (2017)

Steroid-resistant nephrotic syndrome (SRNS) is a frequent cause of chronic kidney disease. Here, we identified recessive mutations in the gene encoding the actin-binding protein advillin (AVIL) in 3 unrelated families with SRNS. While all AVIL mutations resulted in a marked loss of its actin-bundling ability, truncation of AVIL also disrupted colocalization with F-actin, thereby leading to impaired actin binding and severing. Additionally, AVIL colocalized and interacted with the phospholipase enzyme PLCE1 and with the ARP2/3 actin-modulating complex. Knockdown of AVIL in human podocytes reduced actin stress fibers at the cell periphery, prevented recruitment of PLCE1 to the ARP3-rich lamellipodia, blocked EGF-induced generation of diacylglycerol (DAG) by PLCE1, and attenuated the podocyte migration rate (PMR). These effects were reversed by overexpression of WT AVIL but not by overexpression of any of the 3 patient-derived AVIL mutants. The PMR was increased by overexpression of WT Avil or PLCE1, or by EGF stimulation; however, this increased PMR was ameliorated by inhibition of the ARP2/3 complex, indicating that ARP-dependent lamellipodia formation occurs downstream of AVIL and PLCE1 function. Together, these results delineate a comprehensive pathogenic axis of SRNS that integrates loss of AVIL function with alterations in the action of PLCE1, an established SRNS protein.
Post-Transplant Cyclophosphamide Overcomes Graft-Versus-Host Disease Aggravation Induced By Extended Administration of Proteasome Inhibitors
Authors: A. Samer Al-Homsi, Austin Goodyke, Kelli Cole, Marlee Muilenburg, Michael McLane, Sarah Abdel-Mageed, Muneer H. Abidi, Stephanie F. Williams
Journal: Blood (2016)
TCT-244 Comparison of In-hospital Outcomes between Octogenarians and Nonagenarians Undergoing Transcatheter Aortic Valve Replacement with Severe Aortic Stenosis: A Propensity Matched Analysis from National Inpatient Sample
Authors: Rajkumar Doshi, Jay Shah, Pratik Agrawal, Evan Shlofmitz, Tapan Miyani, Perwaiz Meraj
Journal: Journal of the American College of Cardiology (2017)